CIK 0001822791 · Non-accelerated filer<br>Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852828339
- Phone
- 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-21 | General Resonance LLC 10% owner | Sale | −132,891 | $3.01 | $400K | 15,742,030 |
| 2022-04-20 | MATLIN DAVID J Director | Purchase | +132,891 | $3.01 | $400K | 1,844,288 |
| 2022-03-29 | MATLIN DAVID J Director | Purchase | +8,648 | $3.23 | $28K | 1,711,397 |
| 2022-03-28 | MATLIN DAVID J Director | Purchase | +10,000 | $3.10 | $31K | 1,702,749 |
| 2022-03-24 | MATLIN DAVID J Director | Purchase | +20,000 | $2.99 | $60K | 1,692,749 |
| 2022-03-23 | MATLIN DAVID J Director | Purchase | +20,000 | $2.94 | $59K | 1,672,749 |
| 2022-03-21 | MATLIN DAVID J Director | Purchase | +35,000 | $2.90 | $102K | 1,652,749 |
| 2022-03-18 | MATLIN DAVID J Director | Purchase | +20,000 | $2.79 | $56K | 1,617,749 |
| 2022-02-17 | Stevens John Henry Director | Option exercise | +273,194 | $0.53 | $145K | 287,572 |
| 2022-02-17 | Stevens John Henry Director | Option exercise · Stock Options (Right to buy) | −273,194 | 0 | ||
| 2022-02-15 | Mortenson Mark Chief Science Officer | Grant or award · Stock Options (Right to buy) | +200,000 | 200,000 | ||
| 2022-02-15 | Glanzman Robert Chief Medical Officer | Grant or award · Stock Options (Right to buy) | +140,000 | 140,000 | ||
| 2022-02-15 | Etherington Robert Dee Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +69,652 | 69,652 | ||
| 2022-02-15 | Etherington Robert Dee Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +480,000 | 480,000 | ||
| 2022-02-03 | Stevens John Henry Director | Grant or award · Stock Options (Right to buy) | +5,721 | 5,721 | ||
| 2022-02-03 | Ugwumba Chidozie Director | Grant or award · Stock Options (Right to buy) | +5.91 | 5.91 | ||
| 2022-02-03 | Stevens John Henry Director | Grant or award · Stock Options (Right to buy) | +6,219 | 6,219 | ||
| 2022-02-03 | Mosca Alison Director | Grant or award · Stock Options (Right to buy) | +7,587 | 7,587 | ||
| 2022-02-03 | McLaughlin Vallerie Director | Grant or award · Stock Options (Right to buy) | +5,473 | 5,473 | ||
| 2022-02-03 | MATLIN DAVID J Director | Grant or award · Stock Options (Right to buy) | +9,701 | 9,701 |
Page 19 of 22 · 427 trades